Novel Human Influenza A Virus Infection Case Report Form
Reported by:
State: ______________ County: _________________
Date reported to state/local health department State/Local Case ID
__/__/__ ________________
Name of Person Reporting to CDC: Last Name: ___________ First Name: ___________
Phone Number :( )___-_______ Fax Number :( )___-_______ E-Mail: ____________
Patient Demographic Data
Date of Birth: ___/___/___
Race:  American Indian/Alaska Native White
 Asian  Black
 Native Hawaiian/Other Pacific Islander
Ethnicity:  Hispanic  Non-Hispanic
Sex:  Male  Female
Is the patient pregnant?  Yes  No  Unknown
Clinical and Diagnostic Data:
Date of symptom onset: ___/___/___
Signs and symptoms: (check all that apply)
 Fever >38 C (100.4 F) ___________T max  Sore throat
 Feverish but temperature not taken  Conjunctivitis
 Cough  Shortness of breath
 Headache  Diarrhea
 Seizures  Other, specify _______________
Was the patient vaccinated against human influenza in the past year?
 Yes  No  Unknown
If yes, date of vaccination ____/____/____
Type of vaccine:  Inactivated  Live attenuated  Unknown
Did the patient receive antiviral medications?
 Yes  No  Unknown
If yes, complete table below
| Drug | Date Initiated | Date Discontinued | Dosage (if known) | 
| Oseltamivir | 
						 | 
						 | 
						 | 
| Zanamivir | 
						 | 
						 | 
						 | 
| Rimantidine | 
						 | 
						 | 
						 | 
| Amantadine | 
						 | 
						 | 
						 | 
| Other ____________ | 
						 | 
						 | 
						 | 
Laboratory Findings:
Leukopenia (white blood cell count <5,000 leukocytes/mm3)
 Yes  No  Unknown
Lymphopenia (total lymphocytes <800/mm3 or lymphocytes <15% of total WBC)
 Yes  No  Unknown
Thrombocytopenia (total platelets <150,000/mm3)
 Yes  No  Unknown
Does the patient have any underlying medical conditions?
 Yes  No  Unknown
If yes, please specify __________________ __________________ _________________
Does the patient have compromised immune function such as HIV infection, cancer, chronic corticosteroid therapy, diabetes, or organ transplant recipient?
 Yes  No  Unknown
If yes to compromised immune function, specify:
_________________________________________________
Was the patient hospitalized?  Yes  No  Unknown
Did the patient require mechanical ventilation?
 Yes  No  Unknown
Did the patient have a chest x-ray or CAT scan performed?
 Normal  Abnormal  Test not performed  Unknown
If abnormal:
Was there evidence of pneumonia?
 Yes  No  Unknown
Did this patient have acute respiratory distress syndrome?
 Yes  No  Unknown
Did the patient die as a result of this illness?  Yes  No  Unknown
Diagnostic tests:
Test 1
Specimen type:
 NP swab  NP aspirate  Nasal aspirate  Sputum
 Oropharyngeal swab  Endotracheal aspirate  Chest tube fluid
 Broncheoalveolar lavage specimen (BAL) Serology
 Other
Date collected: __/__/__
Test type:
 RT-PCR  Direct fluorescent antibody (DFA)
 Viral culture  Rapid antigen test
Test result:
 Influenza A  Influenza B  Influenza type unknown
 Negative  Pending
Test 2
Specimen type:
 NP swab  NP aspirate  Nasal aspirate  Sputum
 Oropharyngeal swab  Endotracheal aspirate  Chest tube fluid
 Broncheoalveolar lavage specimen (BAL)  Serology
 Other
Date collected: __/__/__
Test type:
 RT-PCR  Direct fluorescent antibody (DFA)
 Viral culture  Rapid antigen test
Test result:
 Influenza A  Influenza B  Influenza type unknown
 Negative  Pending
Indicate when and what type of specimens (including sera) were sent to CDC
__/__/__ Specimen type ___________________________
__/__/__ Specimen type ___________________________
__/__/__ Specimen type ___________________________
Epidemiologic Risk Factors
In the 10 days prior to illness onset, did the patient travel?
 Yes  No  Unknown
If yes, please fill in the arrival and departure dates for all countries visited.
Country____________ Arrival_________________ Departure______________
Country____________ Arrival_________________ Departure______________
Country____________ Arrival_________________ Departure______________
Country____________ Arrival_________________ Departure______________
Country____________ Arrival_________________ Departure______________
The following questions concern the 10 days prior to illness onset…
Did the patient have close contact (within 1 meter (3 feet)) with a person (e.g. caring for, speaking with, or touching) who is a suspected, probable or confirmed novel human influenza A case?
 Yes  No  Unknown
Did the patient touch (handle, slaughter, butcher, prepare for consumption) animals (including poultry, wild birds, or swine) or their remains in an area where influenza infection in animals or novel influenza in humans has been suspected or confirmed in the last month?
 Yes  No  Unknown
Was the patient exposed to animal (including poultry, wild birds, or swine) remains in an area where influenza infection in animals or novel influenza in humans has been suspected or confirmed in the last month?
 Yes  No  Unknown
Was the patient exposed to environments contaminated by to animal feces (including poultry, wild birds, or swine) in an area where influenza infection in animals or novel influenza in humans has been suspected or confirmed in the last month?
 Yes  No  Unknown
Did the patient consume raw or undercooked animals (including poultry, wild birds, or swine products) in an area where influenza infections in animals or novel influenza in humans has been suspected or confirmed in the last month?
 Yes  No  Unknown
Did the patient have any animal contact?
 Yes  No  Unknown
If yes, please specify contact with dogs, cats, horses, wild birds, poultry or swine.
_______________________________________________________
_______________________________________________________________________________________________________________________________________________
Did the patient handle samples (animal or human) suspected of containing influenza virus in a laboratory or other setting?
 Yes  No  Unknown
Does the patient work in a health care facility or setting?
 Yes  No  Unknown
Did the patient visit or stay in the same household with any one with pneumonia or severe influenza-like illness?
 Yes  No  Unknown
Did the patient visit or stay in the same household with anyone who died following the visit?
 Yes  No  Unknown
Did the patient visit an agricultural event, farm, petting zoo or place where pigs live or were exhibited (state or county fair) in the last month?
 Yes  No  Unknown
Did the patient have direct contact with pigs at an agricultural event, farm, petting zoo or place where pigs were exhibited (state or county fair) in the last month?
 Yes  No  Unknown
If this patient has a diagnosis of novel influenza A virus infection that has not been serologically confirmed, is there an epidemiologic link between this patient and a laboratory-confirmed or probable novel influenza A case?
 Yes  No  Unknown
 
	Novel Human Influenza A Case Definition Clinical
	presentation: Illness compatible with influenza virus infection. Laboratory
	evidence: A novel human influenza virus is defined as a influenza A
	virus substantially different from currently circulating human
	influenza H1 and H3 strains such that it cannot be subtyped using
	standard methods and reagents.  This would include influenza A H1
	and H3 viruses of animal origin (e.g. swine and avian H1 and H3
	viruses) and non-H1 or H3 subtype influenza A viruses (e.g. H2, H5,
	H7, and H9 subtypes).  Novel influenza A viruses will be identified
	as unsubtypable with methods available for detection of currently
	circulating human influenza viruses at state public health
	laboratories (e.g., real-time RT-PCR). 
	 Confirmation
	of an influenza A virus as a novel virus will be performed by
	CDC’s influenza laboratory. Criteria for epidemiologic
	linkage: a) the patient has had contact with one or more persons who
	either have/had the disease and b) transmission of the agent by the
	usual modes of transmission is plausible. A case may be considered
	epidemiologically linked to a laboratory-confirmed case if at least
	one case in the chain of transmission is laboratory confirmed. Confirmed
	case: A case of human infection
	with a novel influenza A virus confirmed
	by CDC’s influenza laboratory. Probable
	case: A case meeting the clinical
	criteria and epidemiologically linked to a
	confirmed case, but for which no laboratory testing for influenza
	virus infection has
	been performed. Suspected
	case: A case meeting the clinical
	criteria, pending laboratory confirmation.
	Any case of human infection with an influenza A virus that is different
	from currently circulating human influenza H1 and H3 viruses is classified
	as a suspected case until the confirmation process is complete.
	
	
	
	
	
	
	
| File Type | application/msword | 
| File Title | Novel Human Influenza A Virus Infection Case Report Form | 
| Author | acy9 | 
| Last Modified By | Lenee Blanton | 
| File Modified | 2010-10-27 | 
| File Created | 2009-12-30 |